Information for "Tyagi S, et al. J. Adv. Pharm. Technol. Res. (2011) cited as Ref 382 in DOI: 10.1038/s41392-020-0110-5"
Jump to navigation
Jump to search
View the protection log for this page.
Basic information
| Display title | Tyagi S, et al. J. Adv. Pharm. Technol. Res. (2011) cited as Ref 382 in DOI: 10.1038/s41392-020-0110-5 |
| Default sort key | Tyagi S, et al. J. Adv. Pharm. Technol. Res. (2011) cited as Ref 382 in DOI: 10.1038/s41392-020-0110-5 |
| Page length (in bytes) | 191 |
| Page ID | 14578 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Wikibase.slis.ua.edu item ID | Q9645 |
| Central description | Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Maintenance script (talk | contribs) |
| Date of page creation | 15:06, 20 May 2020 |
| Latest editor | Maintenance script (talk | contribs) |
| Date of latest edit | 15:06, 20 May 2020 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Page properties
| Transcluded templates (6) | Templates used on this page: |
| Wikibase.slis.ua.edu entities used in this page |
|
